Communication

September 2017:

Participation in Forum Emergence from Pôle Cancer BioSanté, Toulouse
Preclinical trials beginning

December 2016:

Participation in the ASH (American Society of Hematology) meeting in San Diego

August 2015:

EUROBIOMED communication for NK-001 selection for FUI funding http://www.eurobiomed.org/fileadmin/user_upload/Presse/150828_communique_EBM_resultats_AAP.pdf

April 2015:

Eurobiomed certification

February 2015:

REEL-R media publication, ”EMERCell, the objective of creating new medication”
http://www.mines-ales.fr/sites/mines-ales.fr/files/reel-r_11_chercheur-se-s_davenir.pdf (p9)

December 2014:

Participation in the ASH (American Society of Hematology) meeting in San Francisco